Works matching IS 01615505 AND DT 2013 AND VI 54 AND IP 11

Results: 32

Atlas of Nuclear Cardiology.

Published in:

Journal of Nuclear Medicine, 2013, v. 54, n. 11, p. 2014, doi. 10.2967/jnumed.113.132191

By:

Kim, E. Edmund

Publication type:

Article

Should Grade of Tracer Uptake on Somatostatin Receptor-Targeted Imaging Be the Major Determinant and Break the Barrier of Histopathologic Criteria for Determining the Suitability of Peptide Receptor Radionuclide Therapy?

Published in:

Journal of Nuclear Medicine, 2013, v. 54, n. 11, p. 2018, doi. 10.2967/jnumed.113.127829

By:

Basu, Sandip

Publication type:

Article

Prognostic Implications of Imaging-Based Bone Marrow Assessment in Lymphoma: 18F-FDG PET, MR Imaging, or 8F-FDG PET/MR Imaging?

Published in:

Journal of Nuclear Medicine, 2013, v. 54, n. 11, p. 2017, doi. 10.2967/jnumed.113.126797

By:

Adams, Hugo J. A.;
Kwee, Thomas C.;
Nievelstein, Rutger A. J.

Publication type:

Article

The Potential for Low-Dose Functional Studies in Maternal-Fetal Medicine Using PET/MR Imaging.

Published in:

Journal of Nuclear Medicine, 2013, v. 54, n. 11, p. 2016, doi. 10.2967/jnumed.113.123919

By:

Jones, Terry;
Budinger, Thomas F.

Publication type:

Article

18F-FDG PET/CT for Early Prediction of Response to Neoadjuvant Lapatinib, Trastuzumab, and Their Combination in HER2-Positive Breast Cancer: Results from Neo-ALTTO.

Published in:

Journal of Nuclear Medicine, 2013, v. 54, n. 11, p. 1855, doi. 10.2967/jnumed.113.126342

By:

Kenny, Laura M.

Publication type:

Article

Acoustic and Photoacoustic Molecular Imaging of Cancer.

Published in:

Journal of Nuclear Medicine, 2013, v. 54, n. 11, p. 1851, doi. 10.2967/jnumed.112.115568

By:

Wilson, Katheryne E.;
Tzu Yin Wang;
Willmann, Jürgen K.

Publication type:

Article

Expanded Programs, Sound Finances for SNMMI.

Published in:

Journal of Nuclear Medicine, 2013, v. 54, n. 11, p. 26N

By:

Pappas, Virginia

Publication type:

Article

Guidance for Reporting in Preclinical Imaging.

Published in:

Journal of Nuclear Medicine, 2013, v. 54, n. 11, p. 25N

By:

Peterson, Todd

Publication type:

Article

Prescriber Beware: It Is III Advised to Administer Compounded Sincalide.

Published in:

Journal of Nuclear Medicine, 2013, v. 54, n. 11, p. 23N

By:

Norenberg, Jeffrey P.;
Ponto, James A.;
Petry, Neil A.;
Wittstrom, Kristina M.

Publication type:

Article

Practical SPECT/CT in Nuclear Medicine.

Published in:

Journal of Nuclear Medicine, 2013, v. 54, n. 11, p. 2014, doi. 10.2967/jnumed.113.132209

By:

Kim, E. Edmund

Publication type:

Article

The SNMMI and EANM Practice Guideline for Small-Bowel and Colon Transit 1.0.

Published in:

Journal of Nuclear Medicine, 2013, v. 54, n. 11, p. 2004, doi. 10.2967/jnumed.113.129973

By:

Maurer, Alan H.;
Camilleri, Michael;
Donohoe, Kevin;
Knight, Linda C.;
Madsen, Jan L.;
Mariani, Giuliano;
Parkman, Henry P.;
Dolsen, Janice Van

Publication type:

Article

Synthetic Lipid Nanoparticles Targeting Steroid Organs.

Published in:

Journal of Nuclear Medicine, 2013, v. 54, n. 11, p. 1996, doi. 10.2967/jnumed.113.121657

By:

Mérian, Juliette;
Boisgard, Raphaël;
Decleves, Xavier;
Thezé, Benoît;
Texier, Isabelle;
Tavitian, Bertrand

Publication type:

Article

Diels-Alder Reaction for Tumor Pre targeting: In Vivo Chemistry Can Boost Tumor Radiation Dose Compared with Directly Labeled Antibody.

Published in:

Journal of Nuclear Medicine, 2013, v. 54, n. 11, p. 1989, doi. 10.2967/jnumed.113.123745

By:

Rossin, Raffaella;
Läppchen, Tilman;
van den Bosch, Sandra M.;
Laforest, Richard;
Robillard, Marc S.

Publication type:

Article

Three Methods for 18F Labeling of the HER2-Binding Affibody Molecule ZHER2:2891 Including Preclinical Assessment.

Published in:

Journal of Nuclear Medicine, 2013, v. 54, n. 11, p. 1981, doi. 10.2967/jnumed.113.122465

By:

Glaser, Matthias;
Iveson, Peter;
Hoppmann, Susan;
Indrevoll, Bârd;
Wilson, Anthony;
Arukwe, Joseph;
Danikas, Antonios;
Bhalla, Rajiv;
Hiscock, Duncan

Publication type:

Article

Nonpolymeric Surface-Coated Iron Oxide Nanoparticles for In Vivo Molecular Imaging: Biodegradation, Biocompatibility, and Multiplatform.

Published in:

Journal of Nuclear Medicine, 2013, v. 54, n. 11, p. 1974, doi. 10.2967/jnumed.113.122267

By:

Chang-Moon Lee;
Su-Jin Cheong;
Eun-Mi Kim;
Seok Tae Lim;
Yong Yeon Jeong;
Myung-Hee Sohn;
Hwan-Jeong Jeong

Publication type:

Article

18F-FDG PET Study Reveals Brain Functional Changes During Attention in Rats.

Published in:

Journal of Nuclear Medicine, 2013, v. 54, n. 11, p. 1969, doi. 10.2967/jnumed.113.123000

By:

Wang Xi;
Danting Su;
Binbin Nie;
Yanqin Yu;
Baoci Shan;
Qiaozhen Chen;
Mei Tian;
Hong Zhang

Publication type:

Article

Awake Nonhuman Primate Brain PET Imaging with Minimal Head Restraint: Evaluation of GABAA-Benzodiazepine Binding with 11C-Flumazenil in Awake and Anesthetized Animals.

Published in:

Journal of Nuclear Medicine, 2013, v. 54, n. 11, p. 1962, doi. 10.2967/jnumed.113.122077

By:

Sandiego, Christine M.;
Xiao Jin;
Mulnix, Tim;
Fowles, Krista;
Labaree, David;
Ropchan, Jim;
Yiyun Huang;
Cosgrove, Kelly;
Castner, Stacy A.;
Williams, Graham V.;
Wells, Lisa;
Rabiner, Eugenii A.;
Carson, Richard E.

Publication type:

Article

N-Acetylcysteine- and MK-801-Induced Changes in Glutamate Levels Do Not Affect In Vivo Binding of Metabotropic Glutamate 5 Receptor Radioligand 11C-ABP688 in Rat Brain.

Published in:

Journal of Nuclear Medicine, 2013, v. 54, n. 11, p. 1954, doi. 10.2967/jnumed.113.121608

By:

Wyckhuys, Tine;
Verhaeghe, Jeroen;
Wyffels, Leonie;
Langlois, Xavier;
Schmidt, Mark;
Stroobants, Sigrid;
Staelens, Steven

Publication type:

Article

Mapping Changes in Mouse Brain Metabolism with PET/CT.

Published in:

Journal of Nuclear Medicine, 2013, v. 54, n. 11, p. 1946, doi. 10.2967/jnumed.113.121509

By:

Welch, Andy;
Mingarelli, Marco;
Riedel, Gemot;
Platt, Bettina

Publication type:

Article

Longitudinal Evaluation of Left Ventricular Substrate Metabolism, Perfusion, and Dysfunction in the Spontaneously Hypertensive Rat Model of Hypertrophy Using Small-Animal PET/CT Imaging.

Published in:

Journal of Nuclear Medicine, 2013, v. 54, n. 11, p. 1938, doi. 10.2967/jnumed.113.120105

By:

Hernandez, Andrew M.;
Huber, Jennifer S.;
Murphy, Stephanie T.;
Janabi, Mustafa;
Zeng, Gengsheng L.;
Brennan, Kathleen M.;
O'Neil, James P.;
Youngho Seo;
Gullberg, Grant T.

Publication type:

Article

Heterogeneity in Intratumor Correlations of 18F-FDG, 18F-FLT, and 61Cu-ATSM PET in Canine Sinonasal Tumors.

Published in:

Journal of Nuclear Medicine, 2013, v. 54, n. 11, p. 1931, doi. 10.2967/jnumed.113.121921

By:

Bradshaw, Tyler J.;
Bowen, Stephen R.;
Jallow, Ngoneh;
Forrest, Lisa J.;
Jeraj, Robert

Publication type:

Article

The Role of Radionuclide Imaging in Epilepsy, Part 2: Epilepsy Syndromes.

Published in:

2013

By:

Kumar, Ajay;
Chugani, Harry T.

Publication type:

journal article

Quantification of the Specific Translocator Protein Signal of 18F-PBR111 in Healthy Humans: A Genetic Polymorphism Effect on In Vivo Binding.

Published in:

Journal of Nuclear Medicine, 2013, v. 54, n. 11, p. 1915, doi. 10.2967/jnumed.113.121020

By:

Qi Guo;
Colasanti, Alessandro;
Owen, David R.;
Onega, Mayca;
Kamalakaran, Aruloly;
Bennacef, Idriss;
Matthews, Paul M.;
Rabiner, Eugenii A.;
Turkheimer, Federico E.;
Gunn, Roger N.

Publication type:

Article

Amyloid-ß Load Predicts Medial Temporal Lobe Dysfunction in Alzheimer Dementia.

Published in:

Journal of Nuclear Medicine, 2013, v. 54, n. 11, p. 1909, doi. 10.2967/jnumed.113.120378

By:

Frings, Lars;
Spehl, Timo S.;
Weber, Wolfgang A.;
Hüll, Michael;
Meyer, Philipp T.

Publication type:

Article

Quantification of Human and Rodent Brown Adipose Tissue Function Using 99mTc-Methoxyisobutylisonitrile SPECT/CT and 99mF-FDG PET/CT.

Published in:

Journal of Nuclear Medicine, 2013, v. 54, n. 11, p. 1896, doi. 10.2967/jnumed.113.121012

By:

Cypess, Aaron M.;
Doyle, Ashley N.;
Sass, Christina A.;
Tian Lian Huang;
Mowschenson, Peter M.;
Rosen, Harold N.;
Yu-Hua Tseng;
Palmer III, Edwin L.;
Kolodny, Gerald M.

Publication type:

Article

Radioembolization for Treatment of Salvage Patients with Colorectal Cancer Liver Metastases: A Systematic Review.

Published in:

Journal of Nuclear Medicine, 2013, v. 54, n. 11, p. 1890, doi. 10.2967/jnumed.113.119545

By:

Rosenbaum, Charlotte E.N.M.;
Verkooijen, Helena M.;
Lam, Marnix G.E.H.;
Smits, Maarten L.J.;
Koopman, Miriam;
van Seeters, Tom;
Vermoolen, Malou A.;
van den Bosch, Maurice A. A. J.

Publication type:

Article

Imaging VCAM-1 as an Indicator of Treatment Efficacy in Metastatic Ovarian Cancer.

Published in:

Journal of Nuclear Medicine, 2013, v. 54, n. 11, p. 1883, doi. 10.2967/jnumed.112.117796

By:

Scalici, Jennifer M.;
Thomas, Stephanie;
Harrer, Christine;
Raines, Timothy A.;
Curran, Joanna;
Atkins, Kristen A.;
Conaway, Mark R.;
Duska, Linda;
Kelly, Kimberly A.;
Slack-Davis, Jill K.

Publication type:

Article

Applying PET to Broaden the Diagnostic Utility of the Clinically Validated CA19.9 Serum Biomarker for Oncology.

Published in:

Journal of Nuclear Medicine, 2013, v. 54, n. 11, p. 1876, doi. 10.2967/jnumed.113.119867

By:

Viola-Villegas, Nerissa Therese;
Rice, Samuel L.;
Carlin, Sean;
Xiaohong Wu;
Evans, Michael J.;
Sevak, Kuntal K.;
Drobjnak, Marija;
Ragupathi, Govind;
Sawada, Ritsuko;
Scholz, Wolfgang W.;
Livingston, Philip O.;
Lewis, Jason S.

Publication type:

Article

64Cu-DOTA-Trastuzumab PET Imaging in Patients with HER2-Positive Breast Cancer.

Published in:

Journal of Nuclear Medicine, 2013, v. 54, n. 11, p. 1869, doi. 10.2967/jnumed.112.118612

By:

Kenji Tamura;
Hiroaki Kurihara;
Kan Yonemori;
Hitoshi Tsuda;
Junko Suzuki;
Yuzuru Kono;
Natsuki Honda;
Makoto Kodaira;
Harukaze Yamamoto;
Mayu Yunokawa;
Chikako Shimizu;
Koki Hasegawa;
Yousuke Kanayama;
Satoshi Nozaki;
Takayuki Kinoshita;
Yasuhiro Wada;
Shusaku Tazawa;
Kazuhiro Takahashi;
Yasuyoshi Watanabe;
Yasuhiro Fujiwara

Publication type:

Article

18F-FDG PET/CT for Early Prediction of Response to Neoadjuvant Lapatinib, Trastuzumab, and Their Combination in HER2-Positive Breast Cancer: Results from Neo-ALTTO.

Published in:

Journal of Nuclear Medicine, 2013, v. 54, n. 11, p. 1862, doi. 10.2967/jnumed.112.119271

By:

Gebhart, Geraldine;
Gámez, Cristina;
Holmes, Eileen;
Robles, Javier;
Garcia, Camilo;
Cortés, Montserrat;
de Azambuja, Evandro;
Fauria, Karine;
Van Dooren, Veerle;
Aktan, Gursel;
Coccia-Portugal, Maria Antonia;
Sung-Bae Kim;
Vuylsteke, Peter;
Cure, Hervé;
Eidtmann, Holger;
Baselga, José;
Piccart, Martine;
Flamen, Patrick;
Di Cosimo, Serena

Publication type:

Article

Long-Term Hematotoxicity After Peptide Receptor Radionuclide Therapy with 177Lu-Octreotate.

Published in:

Journal of Nuclear Medicine, 2013, v. 54, n. 11, p. 1857, doi. 10.2967/jnumed.112.119347

By:

Sabet, Amir;
Ezziddin, Khaled;
Pape, Ulrich-Frank;
Ahmadzadehfar, Hojjat;
Mayer, Karin;
Pöppel, Thorsten;
Guhlke, Stefan;
Biersack, Hans-Jürgen;
Ezziddin, Samer

Publication type:

Article

2013 SNMMI Highlights Lecture: Oncology.

Published in:

Journal of Nuclear Medicine, 2013, v. 54, n. 11, p. 11N

By:

Wahl, Richard L.

Publication type:

Article

Works matching IS 01615505 AND DT 2013 AND VI 54 AND IP 11

Atlas of Nuclear Cardiology.

Should Grade of Tracer Uptake on Somatostatin Receptor-Targeted Imaging Be the Major Determinant and Break the Barrier of Histopathologic Criteria for Determining the Suitability of Peptide Receptor Radionuclide Therapy?

Prognostic Implications of Imaging-Based Bone Marrow Assessment in Lymphoma: <sup>18</sup>F-FDG PET, MR Imaging, or 8F-FDG PET/MR Imaging?

The Potential for Low-Dose Functional Studies in Maternal-Fetal Medicine Using PET/MR Imaging.

<sup>18</sup>F-FDG PET/CT for Early Prediction of Response to Neoadjuvant Lapatinib, Trastuzumab, and Their Combination in HER2-Positive Breast Cancer: Results from Neo-ALTTO.

Acoustic and Photoacoustic Molecular Imaging of Cancer.

Expanded Programs, Sound Finances for SNMMI.

Guidance for Reporting in Preclinical Imaging.

Prescriber Beware: It Is III Advised to Administer Compounded Sincalide.

Practical SPECT/CT in Nuclear Medicine.

The SNMMI and EANM Practice Guideline for Small-Bowel and Colon Transit 1.0.

Synthetic Lipid Nanoparticles Targeting Steroid Organs.

Diels-Alder Reaction for Tumor Pre targeting: In Vivo Chemistry Can Boost Tumor Radiation Dose Compared with Directly Labeled Antibody.

Three Methods for <sup>18</sup>F Labeling of the HER2-Binding Affibody Molecule Z<sub>HER2:2891</sub> Including Preclinical Assessment.

Nonpolymeric Surface-Coated Iron Oxide Nanoparticles for In Vivo Molecular Imaging: Biodegradation, Biocompatibility, and Multiplatform.

<sup>18</sup>F-FDG PET Study Reveals Brain Functional Changes During Attention in Rats.

Awake Nonhuman Primate Brain PET Imaging with Minimal Head Restraint: Evaluation of GABA<sub>A</sub>-Benzodiazepine Binding with <sup>11</sup>C-Flumazenil in Awake and Anesthetized Animals.

N-Acetylcysteine- and MK-801-Induced Changes in Glutamate Levels Do Not Affect In Vivo Binding of Metabotropic Glutamate 5 Receptor Radioligand <sup>11</sup>C-ABP688 in Rat Brain.

Mapping Changes in Mouse Brain Metabolism with PET/CT.

Longitudinal Evaluation of Left Ventricular Substrate Metabolism, Perfusion, and Dysfunction in the Spontaneously Hypertensive Rat Model of Hypertrophy Using Small-Animal PET/CT Imaging.

Heterogeneity in Intratumor Correlations of <sup>18</sup>F-FDG, <sup>18</sup>F-FLT, and <sup>61</sup>Cu-ATSM PET in Canine Sinonasal Tumors.

The Role of Radionuclide Imaging in Epilepsy, Part 2: Epilepsy Syndromes.

Quantification of the Specific Translocator Protein Signal of <sup>18</sup>F-PBR111 in Healthy Humans: A Genetic Polymorphism Effect on In Vivo Binding.

Amyloid-ß Load Predicts Medial Temporal Lobe Dysfunction in Alzheimer Dementia.

Quantification of Human and Rodent Brown Adipose Tissue Function Using <sup>99m</sup>Tc-Methoxyisobutylisonitrile SPECT/CT and <sup>99m</sup>F-FDG PET/CT.

Radioembolization for Treatment of Salvage Patients with Colorectal Cancer Liver Metastases: A Systematic Review.

Imaging VCAM-1 as an Indicator of Treatment Efficacy in Metastatic Ovarian Cancer.

Applying PET to Broaden the Diagnostic Utility of the Clinically Validated CA19.9 Serum Biomarker for Oncology.

<sup>64</sup>Cu-DOTA-Trastuzumab PET Imaging in Patients with HER2-Positive Breast Cancer.

<sup>18</sup>F-FDG PET/CT for Early Prediction of Response to Neoadjuvant Lapatinib, Trastuzumab, and Their Combination in HER2-Positive Breast Cancer: Results from Neo-ALTTO.

Long-Term Hematotoxicity After Peptide Receptor Radionuclide Therapy with <sup>177</sup>Lu-Octreotate.

2013 SNMMI Highlights Lecture: Oncology.